SeekingAlpha · Jan 27, 2026
IBB: Beyond The 2025 Surge, Biotech Breakout
iShares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.
NYSE · IBBQ
Invesco Nasdaq Biotechnology ETF
Financial Services · Asset Management
$34.97
Up+$0.04 (+0.10%)
Updated Sep 25, 2026, 11:05 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 41.2M
- P/E ratio
- —
- Dividend yield
- 0.65%
- 52-week range
- $27.46 – $36.84
- Volume
- 44.75K
- Avg. volume
- 20K
Price performance
IBBQ price history
1M range · 20 trading sessions · Daily adjusted prices
IBBQ closed at $34.97 after 20 trading sessions, down 4.06% for the selected period.
- Last close
- $34.97
- Period change
- -4.06%
- Period low
- $34.25
- Period high
- $36.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $34.52 | $35.03 | $34.49 | $34.97 | 44.75K |
| Sep 23, 2026 | $35.50 | $35.53 | $34.56 | $34.76 | 39.88K |
| Sep 22, 2026 | $35.05 | $35.58 | $34.865 | $35.40 | 51.95K |
| Sep 21, 2026 | $34.59 | $34.9984 | $34.485 | $34.8495 | 37.96K |
| Sep 18, 2026 | $35.13 | $35.13 | $34.6296 | $34.6893 | 25.49K |
| Sep 17, 2026 | $34.94 | $35.21 | $34.905 | $35.1258 | 22.74K |
| Sep 16, 2026 | $34.39 | $34.62 | $34.1992 | $34.3559 | 19.69K |
| Sep 15, 2026 | $34.47 | $34.47 | $34.04 | $34.25 | 37.89K |
| Sep 14, 2026 | $34.52 | $34.92 | $34.42 | $34.82 | 14.09K |
| Sep 11, 2026 | $34.93 | $34.93 | $34.46 | $34.472 | 17.43K |
| Sep 10, 2026 | $34.91 | $34.91 | $34.41 | $34.41 | 19.85K |
| Sep 9, 2026 | $35.20 | $35.3899 | $34.92 | $34.9277 | 14.3K |
| Sep 8, 2026 | $35.59 | $35.6199 | $35.07 | $35.20 | 23.81K |
| Sep 4, 2026 | $36.30 | $36.30 | $35.905 | $36.05 | 12.54K |
| Sep 3, 2026 | $36.39 | $36.52 | $35.9101 | $36.26 | 35.22K |
| Sep 2, 2026 | $35.93 | $36.45 | $35.7472 | $36.30 | 17.94K |
| Sep 1, 2026 | $35.51 | $35.80 | $35.48 | $35.79 | 39.94K |
| Aug 31, 2026 | $35.18 | $35.56 | $34.86 | $35.4742 | 25.72K |
| Aug 28, 2026 | $36.38 | $36.38 | $35.39 | $35.47 | 27.7K |
| Aug 27, 2026 | $36.44 | $36.55 | $36.285 | $36.45 | 37.77K |
Latest IBBQ news
The latest Smart Investors Daily articles mentioning IBBQ.
Stock researchCompany · Overview
IBBQ research
Overview
Company profile and research snapshot.
Company profile
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Zacks Investment Research · Jul 26, 2022
Should You Buy Beaten-Down Biotech Stocks & ETFs?
We highlight 4 ETFs that have started rebounding after a brutal sell-off
Zacks Investment Research · Jun 19, 2021
Dow has Worst Week of the Year on Rate Hike Fears
Dow has Worst Week of the Year on Rate Hike Fears
Zacks Investment Research · Jun 16, 2021
Should You Buy Biotech ETFs Now?
Biotech stocks are rallying this month; can the trend continue?
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
